Compounds > masoprocol

masoprocol and ER-Negative PR-Negative HER2-Negative Breast Cancer

masoprocol has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grossert, A; Kempa, A; Nolte, J; Pöttgen, LA; Schörken, U; Sperlich, J; Teusch, N1

Other Studies

1 other study(ies) available for masoprocol and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Glucansucrase catalyzed synthesis and functional characterization of nordihydroguaiaretic acid glucosides.
    Enzyme and microbial technology, 2019, Volume: 120

    Topics: Antioxidants; Cell Movement; Female; Glucosides; Glycosyltransferases; Humans; Iridoid Glucosides; Larrea; Masoprocol; Triple Negative Breast Neoplasms; Tumor Cells, Cultured

2019